News

Benitec Biopharma CEO and managing director Peter French said that the commencement of this clinical trial of TT-034 represents a landmark in the company’s history. "The trial is

Current investors Atlas Venture and Johnson & Johnson Development (JJDC) led the financing round. Rodin will use the new funds to advance its pipeline of selective epigenetic modulators

Mylan received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prophylaxis

Spectrum Pharmaceuticals chairman and CEO Rajesh Shrotriya said that SPI-2012 is the highest priority drug in the company’s pipeline because of its unique technology, and its potential to

Prior to the meeting with the MPA on 26 May 2014, InSite Vision had submitted substantial preliminary BromSite information to the Agency including CMC (chemistry, manufacturing, and controls)

As part of the deal, facilitated by the Johnson & Johnson Innovation center, Aduro is eligible to get about $365m in upfront license fees and milestone payments following

The EPINEPHRINE INJECTION, USP, 1:1000 (0.3mg Pre-filled single dose syringe) is designed for the emergency treatment of allergic reactions (Type I) including anaphylaxis. The company’s PFS provides a

The global agreement will initially focus on Advaxis’s lead immunotherapy for cervical cancer, ADXS-HPV. As part of the deal, inVentiv will provide Advaxis with full CRO services to

The agreement will allow the company to assess its modified recombinant human albumin (rAlbumin) Veltis technology, to evaluate the dosing and performance of a novel subunit antigen vaccine